ARTICLES

AAN Issues Guidance on the Use of Wearable Devices
Industry News Technology

AAN Issues Guidance on Wearable Devices

Wearable devices and digital apps that are available to consumers are emerging as potential tools in neurological care. These include smart watches and fitness trackers to monitor heart rate, physical activity, sleep and other health factors. To provide neurologists with guidance on the use, limitations and evidence on non-U.S. Food […]

strategic alignment
ARTICLES Clinical Insights Patient Care

Why Are Hospitals Seeking Outsourced Partners, And Who Controls The Patient Pathway?

This rising demand collides with real operational constraints, such as credentialed technologists and physician shortages, aging equipment, getting out in front of evolving billing codes in 2026, and the modifications needed for the type of HST devices utilized, fragmented software, EMR integration requirements, capital constraints, and pressure to expand home‑based […]

Researchers’ Sweat-Based Sensor May Help Improve Sleep Quality
Research/Studies

Researchers’ Sweat-Based Sensor May Help Improve Sleep Quality

University of Texas at Dallas researchers, in partnership with Texas-based biotech company EnLiSense, have demonstrated a pioneering wearable perspiration-based sensor that measures two key hormones that regulate the body’s sleep-wake cycle. The electrochemical sensor continuously monitors cortisol, which promotes wakefulness, and melatonin, which signals the body to sleep. The bioengineers […]

Bleep LLC appoints Thomas P. Beckley to Board of Directors
Industry News

Bleep LLC appoints Thomas P. Beckley to Board of Directors

Bleep LLC, maker of the Eclipse™ mask-less CPAP solution, announced technologist and electronics industry veteran Tom Beckley has joined the Company’s Board of Directors. “As a successful technology entrepreneur with extensive knowledge of AI, software and advanced electro-mechanical systems, I’m very pleased Tom has joined Bleep’s Board of Directors,” said […]

Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
Industry News Insomnia Research/Studies

Nexalin’s HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Insomnia Market

Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]